Fellowship · New York, NY
Sponsored by New York Presbyterian Hospital
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
The New England journal of medicine · 2022 · 277 citations · Vishal Patel
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
The New England journal of medicine · 2025 · 63 citations · Vishal Patel
Acral lentiginous melanoma. Part I. Epidemiology, etiology, clinical presentation, and diagnosis.
Journal of the American Academy of Dermatology · 2026 · 16 citations · Vishal Patel
Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
JAMA dermatology · 2023 · 53 citations · Mary Stevenson
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
The Lancet. Oncology · 2023 · 72 citations · Vishal Patel
Oral minoxidil for late alopecia in cancer survivors.
Breast cancer research and treatment · 2024 · 15 citations · Rachel Reingold
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis.
NPJ digital medicine · 2025 · 10 citations · Mary Stevenson
Overall Survival After Mohs Surgery for Early-Stage Merkel Cell Carcinoma.
JAMA dermatology · 2023 · 18 citations · Mary Stevenson